JAMA Network Home
Sign In
Review

Head and Neck Cancer Salvage Surgery in the Era of Immunotherapy and Beyond

JAMA Otolaryngology–Head & Neck Surgery 10.1001/jamaoto.2025.3204

October 02, 2025 at 11:00 AM EDT

Read the full article

Advances in immunotherapy and the development of future clinical trials incorporating immunotherapy in the HNSCC salvage setting have the potential to enhance patient selection and optimize surgical outcomes.

Corresponding Author: Nabil F. Saba, MD, Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA 30322 (nfsaba@emory.edu).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

https://jamanetwork.com/journals/jamaotolaryngology/fullarticle/10.1001/jamaoto.2025.3204?utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_term=100225

Copy to clipboard

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.

Editor's Picks